REACH Market Research Archives

Browsing: REACH Market Research

MARKETVUE® REPORT: Surgery remains the only option for the ~50% of LQTS patients refractory or intolerant to beta blockers

Health November 7, 2023

LQTS types 2 and 3 have the highest need for novel pharmacologic treatments of all subtypes, according to findings from…

MARKETVUE® REPORT: Arrhythmogenic Cardiomyopathy Gene Therapy Research Gains Momentum

Health November 7, 2023

~70% of physicians surveyed by REACH Market Research report there is an extremely high unmet medical need for novel treatments…

MARKETVUE® REPORT: Gene therapies for treatment of Glycogen Storage Disease Type 1a offer hope for overburdened patients

Health September 28, 2023

Ultragenyx’s AAV8 vector gene therapy, DTX401, is advancing through clinical trials as potentially the first ever therapy to treat Glycogen…

Ophthalmologists estimate 10% of Geographic Atrophy patients are now treated with Syfovre since its February 2023 approval (MARKETVUE® REPORT)

Business August 17, 2023

Apellis’s anti-C3 Syfovre (pegcetacoplan intravitreal injection) and Astellas’ anti-C5 Izervay (avacincaptad pegol intravitreal injection) were both recently FDA-approved to treat…

MARKETVUE® REPORT: Frontal Fibrosing Alopecia burden of disease is significant with half of patients unable to achieve complete response to treatment

Health February 22, 2023

According to REACH Market Research, dermatologists agree that Frontal Fibrosing Alopecia (FFA) is generally more difficult to treat, and less…

What's Hot

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

Browsing: REACH Market Research

MARKETVUE® REPORT: Surgery remains the only option for the ~50% of LQTS patients refractory or intolerant to beta blockers

MARKETVUE® REPORT: Arrhythmogenic Cardiomyopathy Gene Therapy Research Gains Momentum

MARKETVUE® REPORT: Gene therapies for treatment of Glycogen Storage Disease Type 1a offer hope for overburdened patients

Ophthalmologists estimate 10% of Geographic Atrophy patients are now treated with Syfovre since its February 2023 approval (MARKETVUE® REPORT)

MARKETVUE® REPORT: Frontal Fibrosing Alopecia burden of disease is significant with half of patients unable to achieve complete response to treatment

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

smartBreakfast Series 2024: llamada de atención para 2027

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

Must Watch

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

What's Hot

Browsing: REACH Market Research

Subscribe to Updates